Auris Medical AG

Company Listings from SPi: Auris Medical AG

You are here: Home >> SPi Company Listings >> Auris Medical AG

 

Auris Medical AG

Website:
http://

Search for other references to "auris" on SPi News

Latest Auris Medical AG News

Auris Medical Announces Positive Interim Results from AM-201 Phase 1b Study in Antipsychotic-Induced Weight Gain Hamilton, Bermuda, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address importa...... 13:30 GMT Friday 11th October 2019

Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address import...... 14:00 GMT Friday 13th September 2019

Auris Medical Announces Notices of Allowance for U.S. and European Patent Applications Covering Intranasal Betahistine Hamilton, Bermuda, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address import...... 14:00 GMT Wednesday 11th September 2019

Auris Medical Announces Appointment of New Chief Financial Officer Hamilton, Bermuda, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address import...... 12:00 GMT Wednesday 4th September 2019

Auris Medical Announces Formation of Scientific Advisory Board for Tinnitus Programs Hamilton, Bermuda, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address importa...... 14:00 GMT Monday 26th August 2019

Auris Medical Provides Business Update and Reports First Half 2019 Financial Results Hamilton, Bermuda, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address importa...... 12:00 GMT Thursday 15th August 2019

Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo Hamilton, Bermuda, July 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address importa...... 13:30 GMT Tuesday 30th July 2019

Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain Hamilton, Bermuda, July 03, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address importa...... 14:00 GMT Wednesday 3rd July 2019

Auris Medical Holding Ltd Provides Corporate Update Hamilton, Bermuda, May 23, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address importan...... 14:00 GMT Thursday 23rd May 2019

Auris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price Rule Hamilton, Bermuda, May 20, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address importan...... 13:45 GMT Monday 20th May 2019

Buy Auris Medical AG
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us